Renal tumors morbidity

Renal carcinoma continues to be a major cause of morbidity and mortality worldwide (Table 16.12). Last year, approximately 54,000 new renal tumor patients were diagnosed and 13,000 deaths were ascribed to renal cancer in the United States. Renal cell carcinoma (RCC) is the seventh most common neoplasm in American males and the ninth most common neoplasm in females. There is a twofold to threefold male predominance of RCC incidence but no obvious racial predilection. Recognized risk factors include tobacco smoking, obesity (body mass index >29 may double the risk of RCC) and acquired or hereditary polycystic diseases. The classic clinical presentation symptom triad of flank pain, hematuria, and palpable mass is no longer the... 

Neeman Z, Wood BJ (2002) Radiofrequency ablation beyond the liver. Tech Vase Interv Radiol 5(3) 156-163 Ni Y, Miao Y, Mulier S et al (2000) A novel cooled-wet electrode for radiofrequency ablation. Eur Radiol 10(5) 852-854 Ogan K, Jacomides L, Dolmatch BL et al (2002) Percutaneous radiofrequency ablation of renal tumors technique limitations and morbidity. Urology 60(6) 954-958 Pacak K, Fojo T, Goldstein DS et al (2001) Radiofrequency ablation a novel approach for treatment of metastatic pheochromocytoma. J Natl Cancer Inst 93(8) 648-649 Patterson EJ, Scudamore CH, Owen DA et al (1998) Radiofrequency ablation of porcine liver in vivo effects of blood flow and treatment time on lesion size. Ann Surg 227(4) 559-565... 

---